NEWS

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video) .

SonoMotion completes initial close of $11.5 Million Series-C funding round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.

Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL.  Article selected for the cover of the May edition (press release)

SonoMotion treats its 40^th subject in the Break Wave Feasibility First-In-Human clinical trial.

SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.

SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.

SonoMotion initiates First-In-Human clinical trial of its Break Wave^TM stone fragmentation system

SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break Wave^TM First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.

GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.

SonoMotion receives Health Canada ITA approval to initiate its Break Wave^TM First-In-Human clinical trial in Canada.

SonoMotion receives FDA IDE approval to initiate its Break Wave^TM First-In-Human clinical trial in the United States.

GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.

SonoMotion receives a $1.0M SBIR Commercial Readiness Program grant from the NIH for the development of Stone Clear^TM.

SonoMotion closes on a $4.6M Series-A round led by MedVenture Partners Inc. and with a significant participation by Bioventures Investors.

SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break Wave^TM.

SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break Wave^TM.

SonoMotion wins Runner-Up and $50,000 in the prestigious primeUC life science startup competition organized by the University of California and Johnson & Johnson.

Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.

 SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone Clear^TM